No Data
No Data
BofA Securities Maintains CG Oncology(CGON.US) With Buy Rating, Maintains Target Price $65
CG Oncology, Inc. (NASDAQ:CGON) Is a Favorite Amongst Institutional Investors Who Own 62%
Does CG Oncology, Inc. (CGON) Have the Potential to Rally 123.34% as Wall Street Analysts Expect?
CG Oncology Amends Key Executive Employment Agreements
H.C. Wainwright Maintains CG Oncology(CGON.US) With Buy Rating, Maintains Target Price $75
Pfizer Study Impact on CG Oncology to Be Minimal, Says H.C. Wainwright